Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Young Shin | - |
dc.contributor.author | Kim, Min Joo | - |
dc.contributor.author | Sun, Hyun Jin | - |
dc.contributor.author | Kim, Hwan Hee | - |
dc.contributor.author | Shin, Hyo Shik | - |
dc.contributor.author | Kim, Young A. | - |
dc.contributor.author | Oh, Byung-Chul | - |
dc.contributor.author | Cho, Sun Wook | - |
dc.contributor.author | Park, Young Joo | - |
dc.date.available | 2020-02-27T04:42:43Z | - |
dc.date.created | 2020-02-05 | - |
dc.date.issued | 2019-01-01 | - |
dc.identifier.issn | 1078-0432 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1989 | - |
dc.description.abstract | Purpose: TSH suppression is widely used to treat well-differentiated thyroid cancer, while its role in poorly differentiated thyroid cancer (PDTC) is undetermined. Besides thyrocytes, TSH also binds to stromal cells, comprising tumor microenvironments. This study aimed to investigate the effects of TSH on tumor microenvironments in PDTC. Experimental Design: An ectopic tumor model using PDTC cells (BHP10-3SCp and FRO), which exhibit TSH/cAMP-independent cell growth, were treated with TSH. Immunohistochemistry was performed using tissue microarrays from 13 PDTCs. Results: TSH treatment significantly enhanced tumor growth of PDTCs with increased vascularity but not that of breast cancer cells, suggesting this effect is unique to thyroid cancer cells, not stromal cells. TSH significantly upregulated VEGF-A and CXCL8 expressions in BHP10-3SCp cells via AKT and ERK signaling, resulting in higher concentrations of VEGF-A and CXCL8 in conditioned medium of TSH-treated BHP10-3SCp cells (TSH-CM) compared to controls. TSH-CM treatment enhanced tube formation potentials of endothelial cells, and blocking VEGF and/or CXCL8 reduced them. Blocking VEGF and/or CXCL8 also reduced TSH-dependent tumor growth with reduced tumor vasculature in vivo. TSH-treated tumors showed increased macrophage densities, and macrophage inhibition reduced TSH-dependent tumor growth in vivo. In human PDTCs, pre-operative TSH levels were positively associated with VEGF-A and tumor size, and the expression of VEGF-A was positively correlated with CD31, CD163, and CXCL8, and their clinical poor prognosis. Conclusions: Aberrant TSH receptor signaling modulates tumor angiogenesis by stimulating VEGF-A and CXCL8 secretion from PDTC cells and enhances tumor growth; thus, TSH suppression is beneficial for treating PDTCs. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER ASSOC CANCER RESEARCH | - |
dc.relation.isPartOf | CLINICAL CANCER RESEARCH | - |
dc.subject | SERUM THYROTROPIN CONCENTRATIONS | - |
dc.subject | ENDOTHELIAL-CELLS | - |
dc.subject | NA+/I-SYMPORTER | - |
dc.subject | IN-VITRO | - |
dc.subject | TSH | - |
dc.subject | EXPRESSION | - |
dc.subject | CARCINOMA | - |
dc.subject | MANAGEMENT | - |
dc.subject | ASSOCIATION | - |
dc.subject | FEATURES | - |
dc.title | Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000455001100042 | - |
dc.identifier.doi | 10.1158/1078-0432.CCR-18-0663 | - |
dc.identifier.bibliographicCitation | CLINICAL CANCER RESEARCH, v.25, no.1, pp.414 - 425 | - |
dc.identifier.scopusid | 2-s2.0-85059476577 | - |
dc.citation.endPage | 425 | - |
dc.citation.startPage | 414 | - |
dc.citation.title | CLINICAL CANCER RESEARCH | - |
dc.citation.volume | 25 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Oh, Byung-Chul | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | SERUM THYROTROPIN CONCENTRATIONS | - |
dc.subject.keywordPlus | ENDOTHELIAL-CELLS | - |
dc.subject.keywordPlus | NA+/I-SYMPORTER | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | TSH | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | FEATURES | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.